Éric Audemard

Récents

• Immunotherapeutic targeting of surfaceome heterogeneity in AML
• High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
• Targeted variant detection using unaligned RNA-Seq reads
• Noncoding regions are the main source of targetable tumor-specific antigens